Biosimilar Market: Information By Product (Recombinant Peptides), Disease (Oncology, Chronic Diseases, Blood Disorders), and Manufacturing (In-House Manufacturing)—Forecast Till 2027

Feb 21, 2020   Global Statistics Representing Biosimilar Market Scenario Biosimilar is a biologic medical product, which is similar to the originator biologic products. As per the European Medicines Agency (EMA), a biosimilar is biomedicine that has the same characteristics as the biomedicines licensed in the European Union (EU). For the record, early biologics, erythropoietin (EPO), insulin, and growth hormones have been invaluable for the treatment and medication of major illnesses, such as anemia, renal di...
TABLE OF CONTENT

Table Of Content

TABLE OF CONTENTS

1          Introduction

1.1       Market Definition

1.2       Market Scope

2          Research Methodology

2.1       Primary Research

2.2       Research Methodology

2.3       Assumptions & Exclusions

2.4       Secondary Data Sources

3          Market Overview

3.1       Report Segmentation & Scope

3.2       Value Chain Analysis: Biosimilars Market

3.3       Key Market Trends

3.3.1   Drivers

3.3.2   Restraints

3.3.3   Opportunities

3.4       Porter’s Five Forces Analysis

3.4.1   Bargaining Power of Suppliers

3.4.2   Bargaining Power of Buyers

3.4.3   Threat of Substitution

3.4.4   Threat of New Entrants

3.4.5   Competitive Rivalry

3.5       Market Share Analysis

4          Product Overview

4.1       Introduction

4.1.1   Market Size & Forecast (Value)

4.2       Recombinant Non-Glycosylated Proteins

4.2.1   Market Size & Forecast (Value)

4.3       Recombinant Glycosylated Proteins

4.3.1   Market Size & Forecast (Value)

4.4       Recombinant Peptides

4.4.1   Market Size & Forecast (Value)

5          Manufacturing Overview

5.1       Introduction

5.1.1   Market Size & Forecast (Value)

5.2       Contract Manufacturing

5.2.1   Market Size & Forecast (Value)

5.3       In-House Manufacturing

5.3.1   Market Size & Forecast (Value)

6          Regional Overview

6.1      Introduction

6.1.1   Market Size & Forecast (Value)

6.2      America

6.2.1   North America

6.2.1.1 U.S.

6.2.1.1.1         By Product

6.2.1.1.2         By Manufacturing

6.2.1.2 Canada

6.2.1.2.1         By Product

6.2.1.2.2         By Manufacturing

6.2.1.3 Mexico

6.2.1.3.1         By Product

6.2.1.3.2         By Manufacturing

6.2.2   Latin America

6.2.2.1      By Product

6.2.2.2      By Manufacturing

6.2.2.2.1   Brazil

6.2.2.2.1.1      By Product

6.2.2.2.1.2      By Manufacturing

6.2.2.2.2   Argentina

6.2.2.2.2.1      By Product

6.2.2.2.2.2      By Manufacturing

6.2.2.2.3   Rest of South America

6.2.2.2.3.1      By Product

6.2.2.2.3.2      By Manufacturing

6.3      Europe

6.3.1   Market Size & Forecast (Value)

6.3.2   Western Europe

6.3.2.1 U.K

6.3.2.1.1         By Product

6.3.2.1.2         By Manufacturing

6.3.2.2 Germany

6.3.2.2.1         By Product

6.3.2.2.2         By Manufacturing

6.3.2.3 France

6.3.2.3.1         By Product

6.3.2.3.2         By Manufacturing

6.3.2.4 Spain

6.3.2.4.1         By Product

6.3.2.4.2         By Manufacturing

6.3.2.5 Italy

6.3.2.5.1         By Product

6.3.2.5.2         By Manufacturing

6.3.2.6 Rest of Western Europe

6.3.2.6.1         By Product

6.3.2.6.2         By Manufacturing

6.3.3   Eastern Europe

6.3.3.1             By Product

6.3.3.2             By Manufacturing

6.4      Asia Pacific

6.4.1   Market Size & Forecast (Value)

6.4.2   Japan

6.4.2.1            By Product

6.4.2.2            By Manufacturing

6.4.3   China

6.4.3.1            By Product

6.4.3.2            By Manufacturing

6.4.4   Australia

6.4.4.1            By Product

6.4.4.2            By Manufacturing

6.4.5   India

6.4.5.1            By Product

6.4.5.2            By Manufacturing

6.4.6   South Korea

6.4.6.1            By Product

6.4.6.2            By Manufacturing

6.4.7   Rest of Asia-Pacific

6.4.7.1            By Product

6.4.7.2            By Manufacturing

6.5      Middle East & Africa

6.5.1   The Middle East

6.5.1.1            Market Size & Forecast (Value)

6.5.1.2            Saudi Arabia

6.5.1.2.1         By Product

6.5.1.2.2         By Manufacturing

6.5.1.3 UAE

6.5.1.3.1         By Product

6.5.1.3.2         By Manufacturing

6.5.1.4 Qatar

6.5.1.4.1         By Product

6.5.1.4.2         By Manufacturing

6.5.2   The Africa

6.5.2.1            Market Size & Forecast (Value)

7          Company Profile

7.1      Biocon

7.1.1   Company Overview

7.1.2   Financial Performance

7.1.3   Recent Developments

7.1.4   Product Portfolio

7.2      Pfizer, Inc.

7.2.1   Company Overview

7.2.2   Financial Performance

7.2.3   Recent Developments

7.2.4   Product Portfolio

7.3      Intas Pharmaceutical Ltd.

7.3.1   Company Overview

7.3.2   Financial Performance

7.3.3   Recent Developments

7.3.4   Product Portfolio

7.4      Dr. Reddy’s Laboratories Ltd.

7.4.1   Company Overview

7.4.2   Financial Performance

7.4.3   Recent Developments

7.4.4   Product Portfolio

7.5      Sandoz International GmbH (A Novartis Division)

7.5.1   Company Overview

7.5.2   Financial Performance

7.5.3   Recent Developments

7.5.4   Product Portfolio

7.6      Celltrion Inc.

7.6.1   Company Overview

7.6.2   Financial Performance

7.6.3   Recent Developments

7.6.4   Product Portfolio

7.7      Teva Pharmaceutical Industries Ltd.

7.7.1   Company Overview

7.7.2   Financial Performance

7.7.3   Recent Developments

7.7.4   Product Portfolio

7.8      STADA Arzneimittel AG

7.8.1   Company Overview

7.8.2   Financial Performance

7.8.3   Recent Developments

7.8.4   Product Portfolio

7.9       Amgen, Inc.

7.9.1   Company Overview

7.9.2   Financial Performance

7.9.3   Recent Developments

7.9.4   Product Portfolio

7.10     Apotex Inc.

7.10.1 Company Overview

7.10.2 Financial Performance

7.10.3 Recent Developments

7.10.4 Product Portfolio